Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,724 | 899 | 97.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $174.82 | 10 | 1.2% |
| Education | $109.42 | 6 | 0.8% |
| Gift | $51.35 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,764 | 132 | $0 (2024) |
| Biogen, Inc. | $1,660 | 90 | $0 (2024) |
| ABBVIE INC. | $865.58 | 68 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $825.35 | 57 | $0 (2024) |
| UCB, Inc. | $573.27 | 35 | $0 (2024) |
| Genentech USA, Inc. | $484.18 | 29 | $0 (2024) |
| Eisai Inc. | $482.69 | 31 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $455.14 | 30 | $0 (2022) |
| Amgen Inc. | $399.85 | 25 | $0 (2024) |
| Allergan, Inc. | $351.13 | 25 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,567 | 109 | Novartis Pharmaceuticals Corporation ($333.23) |
| 2023 | $1,894 | 113 | Biogen, Inc. ($292.94) |
| 2022 | $1,960 | 127 | Novartis Pharmaceuticals Corporation ($274.84) |
| 2021 | $1,851 | 126 | Biogen, Inc. ($234.16) |
| 2020 | $1,651 | 108 | Novartis Pharmaceuticals Corporation ($196.84) |
| 2019 | $1,552 | 109 | Novartis Pharmaceuticals Corporation ($294.00) |
| 2018 | $1,414 | 102 | Biogen, Inc. ($151.36) |
| 2017 | $2,171 | 124 | Allergan Inc. ($226.34) |
All Payment Transactions
918 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Neurology | ||||||
| 12/06/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Central Nervous System | ||||||
| 12/02/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $7.04 | General |
| Category: Neurology | ||||||
| 11/19/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Neurology | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Neurology | ||||||
| 11/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Neuroscience | ||||||
| 11/05/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/02/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 11/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: PAIN | ||||||
| 10/29/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Central Nervous System | ||||||
| 10/28/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: NEUROLOGY | ||||||
| 10/22/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Neuropsychiatry | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: Neurology | ||||||
| 10/14/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Neurology | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Neurology | ||||||
| 10/08/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $17.90 | General |
| Category: NEUROLOGY | ||||||
| 10/04/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 10/04/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 10/02/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 09/27/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Neurology | ||||||
| 09/27/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $4.42 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 407 | 585 | $269,400 | $62,626 |
| 2022 | 5 | 403 | 573 | $214,165 | $50,082 |
| 2021 | 6 | 439 | 580 | $172,435 | $42,238 |
| 2020 | 7 | 434 | 536 | $155,060 | $31,821 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 209 | 377 | $163,475 | $39,317 | 24.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 78 | 78 | $57,960 | $14,326 | 24.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 26 | $15,760 | $4,072 | 25.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 66 | 68 | $21,075 | $3,372 | 16.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 29 | 36 | $11,130 | $1,539 | 13.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 203 | 362 | $112,040 | $26,372 | 23.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 73 | 73 | $41,200 | $10,344 | 25.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 30 | 30 | $22,330 | $5,504 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 43 | $18,685 | $4,567 | 24.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 43 | 51 | $15,710 | $3,060 | 19.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 14 | 14 | $4,200 | $234.68 | 5.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 184 | 289 | $73,695 | $16,106 | 21.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 93 | 117 | $29,835 | $8,178 | 27.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 47 | 47 | $25,850 | $5,336 | 20.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 43 | 53 | $11,660 | $4,038 | 34.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 16 | 16 | $11,040 | $2,978 | 27.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 28 | 30 | $11,100 | $2,485 | 22.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 15 | $5,550 | $1,690 | 30.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 13 | 13 | $3,705 | $1,427 | 38.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 152 | 233 | $59,415 | $12,201 | 20.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 46 | 46 | $25,300 | $4,765 | 18.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 86 | 102 | $26,010 | $3,882 | 14.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 24 | 24 | $16,560 | $3,841 | 23.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 43 | 45 | $9,900 | $2,715 | 27.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 19 | 20 | $7,400 | $1,897 | 25.6% |
About Dr. Michael Merkin, MD
Dr. Michael Merkin, MD is a Neurology healthcare provider based in Edison, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669548079.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Merkin, MD has received a total of $14,059 in payments from pharmaceutical and medical device companies, with $1,567 received in 2024. These payments were reported across 918 transactions from 63 companies. The most common payment nature is "Food and Beverage" ($13,724).
As a Medicare-enrolled provider, Merkin has provided services to 1,683 Medicare beneficiaries, totaling 2,274 services with total Medicare billing of $186,768. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Edison, NJ
- Active Since 11/28/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1669548079
Products in Payments
- KESIMPTA (Drug) $974.71
- TYSABRI (Biological) $817.66
- QULIPTA (Drug) $423.48
- OCREVUS (Biological) $363.47
- UBRELVY (Drug) $361.08
- Aimovig (Biological) $353.29
- Fycompa (Drug) $349.10
- VUMERITY (Drug) $348.06
- ZEPOSIA (Drug) $340.96
- APTIOM (Drug) $312.09
- Briviact (Drug) $309.85
- RYTARY (Drug) $306.72
- NUPLAZID (Drug) $303.58
- AVONEX (Biological) $290.10
- AUBAGIO (Drug) $289.54
- MAYZENT (Drug) $263.21
- GILENYA (Drug) $261.71
- TROKENDI XR (Drug) $248.84
- NUEDEXTA (Drug) $223.30
- AJOVY (Biological) $217.32
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Edison
Dr. Marina Sobol, M.d, M.D
Neurology — Payments: $69,571
Dr. Wei Ma, Md, MD
Neurology — Payments: $61,842
Dr. Siddharth Kapoor, Md, MD
Neurology — Payments: $50,944
Philip Hanna, Md, MD
Neurology — Payments: $21,708
Dr. Adel Aziz, Md, MD
Neurology — Payments: $19,724
Dr. Lewis Milrod, M.d, M.D
Neurology — Payments: $19,295